Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression. [electronic resource]
Producer: 20120322Description: 15-9 p. digitalISSN:- 1502-7732
- Antibodies, Monoclonal -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- diagnostic imaging
- Blood Sedimentation -- drug effects
- C-Reactive Protein -- drug effects
- Disability Evaluation
- Disease Progression
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Infliximab
- Logistic Models
- Male
- Methotrexate -- therapeutic use
- Pain Measurement -- drug effects
- Prednisone -- therapeutic use
- Prognosis
- Radiography
- Randomized Controlled Trials as Topic
- Risk Assessment
- Severity of Illness Index
- Sulfasalazine -- therapeutic use
- Surveys and Questionnaires
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.